These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7734216)

  • 21. Hereditary cancer syndromes, their testing and prevention.
    Foretová L
    Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indicators within the framework of a multiphase screening program for the prevention of malignant neoplasms in common sites].
    Burány B; Szabó E; Leiszmeiszter A; Kosiczky F; Berta M; Molnár M
    Med Pregl; 1987; 40(7-8):319-22. PubMed ID: 3451041
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing for cancer susceptibility genes in children.
    Laxova R
    Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole Exome Sequencing: The Next Phase of Genetics Care.
    Mahon SM
    Oncol Nurs Forum; 2016 Mar; 43(2):249-52. PubMed ID: 26906136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary colorectal cancer: more common than you think.
    Jasperson KW
    Curr Probl Cancer; 2014; 38(6):249-61. PubMed ID: 25497411
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic testing.
    Petersen GM
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):939-52. PubMed ID: 10949782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection and risk reduction for familial gynecologic cancers.
    Chen LM; Karlan BY
    Clin Obstet Gynecol; 1998 Mar; 41(1):200-14. PubMed ID: 9504236
    [No Abstract]   [Full Text] [Related]  

  • 28. [DNA microarrays in the clinic?].
    Jordan B
    Med Sci (Paris); 2007 Feb; 23(2):210-4. PubMed ID: 17291433
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetics of cancer: current knowledge and future possibilities.
    Evans DG
    Hosp Med; 1998 Dec; 59(12):920-3. PubMed ID: 10696352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical genetic services for familial breast cancer in Poland.
    Gronwald J; Menkiszak J; Huzarski T; Byrski T; Jakubowska A; Zajàczek S; Toloczko A; Podolski J; Górecka B; Zdziebkowska H; Stanislawski P; Stawicka M; Lubinski J
    Dis Markers; 1999 Oct; 15(1-3):46. PubMed ID: 10595252
    [No Abstract]   [Full Text] [Related]  

  • 31. [Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation].
    Krainer M; Zojer N; Mannhalter C
    Geburtshilfe Frauenheilkd; 1995 Jul; 55(7):M73-6. PubMed ID: 7557194
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
    Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
    Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
    [No Abstract]   [Full Text] [Related]  

  • 33. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing.
    Spoto CPE; Gullo I; Carneiro F; Montgomery EA; Brosens LAA
    Semin Diagn Pathol; 2018 May; 35(3):170-183. PubMed ID: 29397239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of DNA diagnostics.
    Critchfield GC
    Dis Markers; 1999 Oct; 15(1-3):108-11. PubMed ID: 10595261
    [No Abstract]   [Full Text] [Related]  

  • 35. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 37. The biology of inherited cancer.
    Lindblom A; Nordenskjöld M
    Semin Cancer Biol; 2000 Aug; 10(4):251-4. PubMed ID: 10966848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer prevention and detection: from twenty to sixty-five years of age.
    White LN
    Oncol Nurs Forum; 1986; 13(2):59-64. PubMed ID: 3633577
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on cancer-preventive therapeutics.
    Brenner DE
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):25-6, 64. PubMed ID: 16163155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.